JWH-307
JWH-307 is a synthetic cannabinoid from the naphthoylindole family. It acts as a potent agonist for the cannabinoid receptors, with a particular preference for the CB1 receptor.
Chemical Structure[edit]
JWH-307 has the chemical formula C24H22O2 and a molecular weight of 342.43 g/mol. The structure includes a naphthalene ring substituted with a methoxy group and a phenyl ring substituted with a ketone group.
Pharmacology[edit]
JWH-307 is known to bind to the CB1 receptor and CB2 receptor, mimicking the effects of tetrahydrocannabinol (THC), the active component of cannabis. It is part of a class of compounds that were initially developed for research purposes but have since been found in synthetic cannabis products.
Legal Status[edit]
JWH-307 is classified as a Schedule I controlled substance in the United States, indicating that it is considered to have a high potential for abuse and no accepted medical use. In the United Kingdom, it is classified as a Class B drug. It is also controlled under similar regulations in other countries, including Canada and Germany.
Related Compounds[edit]
JWH-307 is part of a larger family of synthetic cannabinoids, including:
See Also[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
